PremiumThe FlySummit Therapeutics down 32% after resuming trading Summit Therapeutics trading resumes Summit Therapeutics to resume trading at 3:20 pm ET PremiumThe FlySummit Therapeutics sinks after STAT report on ivonescimab data Summit Therapeutics trading halted, news pending Summit Therapeutics trading resumes PremiumRatingsMitchell Kapoor Reaffirms Buy Rating for Summit Therapeutics Amid Promising Ivonescimab Trial Results Positive Phase 3 Trial Results for Ivonescimab Boost Confidence in Summit Therapeutics’ NSCLC Prospects Akeso reports results from HARMONi-6 Phase III clinical trial